Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edwin Gravereaux

Vascular Surgery Boston, MA Medical Doctor

NPI 1376500751 CMS profile 61582

75 Francis St, Brigham And Women's Hospital, Boston, MA 02115

Open in the dashboard

General payments

$61,042

162 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edwin Gravereaux of Boston, MA is reported in the CMS Open Payments database as having received $61,042 across 162 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,697 13
2024 General $15,866 25
2023 General $14,586 35
2022 General $8,169 27
2021 General $11,793 22
2020 General $1,454 18
2019 General $5,476 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edwin Gravereaux
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Edwin Gravereaux were reported at $3,697. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Edwin Gravereaux Vascular Surgery median Middle half National median
2019 $5,476 $796 $226–$2,363 $163
2020 $1,454 $348 $118–$1,110 $114
2021 $11,793 $471 $158–$1,421 $132
2022 $8,169 $725 $222–$2,183 $149
2023 $14,586 $836 $257–$2,440 $160
2024 $15,866 $909 $252–$2,619 $164
2025 $3,697 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Maquet Cardiovascular L.L.C. $38,375 13 payments
  2. Abbott Laboratories $10,045 25 payments
  3. Surmodics, Inc. $4,250 7 payments
  4. Endologix, Inc. $4,132 88 payments
  5. Penumbra, Inc. $1,388 5 payments
  6. Shockwave Medical, Inc $797 9 payments
  7. Intervascular $715 1 payment
  8. Inari Medical, Inc. $574 4 payments
  9. Cardiovascular Systems Inc. $303 4 payments
  10. Veryan Medical Incorporated $185 2 payments
  11. Other $278 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $53,385 46 payments
  2. Food and Beverage $6,454 114 payments
  3. Travel and Lodging $1,202 2 payments
Products named General payments · program years 2019–2025
  1. Vasoview Hemopro 2 $18,868 4 payments
  2. ROTAFLOW $11,790 4 payments
  3. iCAST $4,305 3 payments
  4. SurVeil $4,250 7 payments
  5. FLIXENE $3,413 2 payments
  6. TENDYNE $1,695 5 payments
  7. ESPRIT $1,050 2 payments
  8. XIENCE SIERRA $1,000 2 payments
  9. Indigo $739 1 payment
  10. INTERGARD $715 1 payment
  11. Other $4,576 62 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$70,898

Medicare's payments for the services billed

Medicare patients

368

Average age 75

Services billed

530

161 women, 207 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Ischemic heart disease 47%
Diabetes 36%
Chronic kidney disease 34%
Atrial fibrillation 27%
COPD 26%
Cancer 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

162 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record